Pabitra Bikash Pal

2.6k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

Pabitra Bikash Pal is a scholar working on Pharmacology, Cell Biology and Surgery. According to data from OpenAlex, Pabitra Bikash Pal has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Cell Biology and 5 papers in Surgery. Recurrent topics in Pabitra Bikash Pal's work include Aldose Reductase and Taurine (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Heavy Metal Exposure and Toxicity (2 papers). Pabitra Bikash Pal is often cited by papers focused on Aldose Reductase and Taurine (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Heavy Metal Exposure and Toxicity (2 papers). Pabitra Bikash Pal collaborates with scholars based in India and United States. Pabitra Bikash Pal's co-authors include Parames C. Sil, Krishnendu Sinha, Joydeep Das, Himangshu Sonowal, Kota V. Ramana, Kirtikar Shukla, Satish K. Srivastava, Sukanya Saha, Pritam Sadhukhan and Jake J. Wen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Pabitra Bikash Pal

17 papers receiving 2.1k citations

Hit Papers

Oxidative stress: the mitochondria-dependent and mitochon... 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pabitra Bikash Pal India 15 844 216 215 193 191 17 2.1k
Krishnendu Sinha India 17 903 1.1× 244 1.1× 208 1.0× 221 1.1× 200 1.0× 28 2.4k
Xue Han China 26 812 1.0× 179 0.8× 166 0.8× 238 1.2× 160 0.8× 99 2.1k
Hamid Mollazadeh Iran 26 663 0.8× 362 1.7× 153 0.7× 266 1.4× 135 0.7× 49 2.0k
Ruyuan Zhu China 23 965 1.1× 306 1.4× 158 0.7× 242 1.3× 216 1.1× 46 1.9k
Yanhua Xie China 26 930 1.1× 379 1.8× 178 0.8× 222 1.2× 156 0.8× 90 2.2k
Tusty‐Jiuan Hsieh Taiwan 31 954 1.1× 124 0.6× 165 0.8× 199 1.0× 201 1.1× 92 2.7k
Xin Jin China 25 754 0.9× 195 0.9× 178 0.8× 129 0.7× 319 1.7× 69 2.0k
Heqing Huang China 31 1.3k 1.5× 339 1.6× 305 1.4× 311 1.6× 187 1.0× 95 2.7k
Layasadat Khorsandi Iran 31 810 1.0× 169 0.8× 169 0.8× 320 1.7× 194 1.0× 177 3.0k
Yuanyuan Cheng China 25 986 1.2× 175 0.8× 212 1.0× 149 0.8× 172 0.9× 113 1.9k

Countries citing papers authored by Pabitra Bikash Pal

Since Specialization
Citations

This map shows the geographic impact of Pabitra Bikash Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pabitra Bikash Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pabitra Bikash Pal more than expected).

Fields of papers citing papers by Pabitra Bikash Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pabitra Bikash Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pabitra Bikash Pal. The network helps show where Pabitra Bikash Pal may publish in the future.

Co-authorship network of co-authors of Pabitra Bikash Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Pabitra Bikash Pal. A scholar is included among the top collaborators of Pabitra Bikash Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pabitra Bikash Pal. Pabitra Bikash Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gupta, Biki, Ravi Rai, Pabitra Bikash Pal, et al.. (2024). Selective Targeting of α4β7/MAdCAM-1 Axis Suppresses Fibrosis Progression by Reducing Proinflammatory T Cell Recruitment to the Liver. Cells. 13(9). 756–756. 5 indexed citations
2.
Pal, Pabitra Bikash, Himangshu Sonowal, Kirtikar Shukla, Satish K. Srivastava, & Kota V. Ramana. (2019). Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway. Journal of Molecular Endocrinology. 63(1). 11–25. 60 indexed citations
3.
Sonowal, Himangshu, Pabitra Bikash Pal, Kirtikar Shukla, et al.. (2018). Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction. Biochemical Pharmacology. 150. 181–190. 29 indexed citations
4.
Sonowal, Himangshu, et al.. (2017). Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. Scientific Reports. 7(1). 3182–3182. 73 indexed citations
5.
Sonowal, Himangshu, Pabitra Bikash Pal, Kirtikar Shukla, & Kota V. Ramana. (2017). Aspalatone Prevents VEGF‐Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells. Oxidative Medicine and Cellular Longevity. 2017(1). 2769347–2769347. 18 indexed citations
6.
Shukla, Kirtikar, Pabitra Bikash Pal, Himangshu Sonowal, Satish K. Srivastava, & Kota V. Ramana. (2017). Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant Proteins. Journal of Diabetes Research. 2017. 1–9. 16 indexed citations
7.
Sonowal, Himangshu, Pabitra Bikash Pal, Satish K. Srivastava, & Kota V. Ramana. (2017). Abstract 1052: Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiomyopathy. Cancer Research. 77(13_Supplement). 1052–1052. 1 indexed citations
8.
Pal, Pabitra Bikash, Himangshu Sonowal, Kirtikar Shukla, Satish K. Srivastava, & Kota V. Ramana. (2017). Aldose Reductase Mediates NLRP3 Inflammasome–Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice. Endocrinology. 158(10). 3661–3675. 51 indexed citations
10.
Sinha, Krishnendu, Pritam Sadhukhan, Sukanya Saha, Pabitra Bikash Pal, & Parames C. Sil. (2015). Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(4). 769–783. 97 indexed citations
12.
Sinha, Krishnendu, Pabitra Bikash Pal, & Parames C. Sil. (2013). Cadmium (Cd2+) exposure differentially elicits both cell proliferation and cell death related responses in SK-RC-45. Toxicology in Vitro. 28(2). 307–318. 26 indexed citations
13.
Bhattacharyya, Sudip, Pabitra Bikash Pal, & Parames C. Sil. (2013). A 35 kD Phyllanthus niruri protein modulates iron mediated oxidative impairment to hepatocytes via the inhibition of ERKs, p38 MAPKs and activation of PI3k/Akt pathway. Food and Chemical Toxicology. 56. 119–130. 23 indexed citations
14.
Pal, Pabitra Bikash, Krishnendu Sinha, & Parames C. Sil. (2013). Mangiferin, a Natural Xanthone, Protects Murine Liver in Pb(II) Induced Hepatic Damage and Cell Death via MAP Kinase, NF-κB and Mitochondria Dependent Pathways. PLoS ONE. 8(2). e56894–e56894. 83 indexed citations
15.
Sinha, Krishnendu, Joydeep Das, Pabitra Bikash Pal, & Parames C. Sil. (2013). Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Archives of Toxicology. 87(7). 1157–1180. 1384 indexed citations breakdown →
16.
Pal, Pabitra Bikash, et al.. (2012). Traditional extract of Pithecellobium dulce fruits protects mice against CCl4 induced renal oxidative impairments and necrotic cell death. Pathophysiology. 19(2). 101–114. 18 indexed citations
17.
Pal, Pabitra Bikash, et al.. (2011). Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. 283(2-3). 129–139. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026